HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.
Boni C, Barili V, Acerbi G, Rossi M, Vecchi A, Laccabue D, Penna A, Missale G, Ferrari C, Fisicaro P.
Boni C, et al.
Int J Mol Sci. 2019 Jun 5;20(11):2754. doi: 10.3390/ijms20112754.
Int J Mol Sci. 2019.
PMID: 31195619
Free PMC article.
Review.
In this perspective, the enhancement of adaptive immune responses by a checkpoint inhibitor blockade, specific T cell vaccines, lymphocyte metabolism targeting, and autologous T cell engineering, including chimeric antigen receptor (CAR) and TCR-redirected T cells, constitutes a …
In this perspective, the enhancement of adaptive immune responses by a checkpoint inhibitor blockade, specific T cell vaccines, lymphocyte m …